IFNG and neoplasm: Induction of HLA-II expression on tumor cells has been attributed to IFN-γ exposure (de Bruin et al., 2008), indicating that the tumor microenvironment and infiltrating immune cells contribute to a favorable clinical outcome (Galon et al., 2006).